Novel dual-therapy approaches targeting CK1/CK2-regulated pathways have further improved the therapeutic specificity and efficacy and hold great promise for selectively targeting cancer-causing signaling pathways and advancing cancer precision medicine.
P. Waghmare, A. Chabukswar, K. Raut et al.· Mini-Reviews in Medical Chem...· 0 citations
AI-driven approaches in transcription modulator discovery are highlighted, including in silico target identification, multi-omics integration, and structure–activity optimization, and the importance of explainable AI and personalised therapeutics in advancing precision medicine and next-generation transcription-based d...
A. Pimpale, P. Waghmare, Pallavi Zode et al.· Journal of Applied Pharmaceu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.